Tetrahydroxystilbene glucoside modulates amyloid precursor protein processing via activation of AKT-GSK3β pathway in cells and in APP/PS1 transgenic mice.
暂无分享,去创建一个
[1] Lan Zhang,et al. TETRAHYDROXYSTILBENE GLUCOSIDE AMELIORATES MEMORY AND MOVEMENT FUNCTIONS, PROTECTS SYNAPSES AND INHIBITS α-SYNUCLEIN AGGREGATION IN HIPPOCAMPUS AND STRIATUM IN AGED MICE , 2017, Alzheimer's & Dementia.
[2] Linhong Huang,et al. Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease. , 2013, Toxicology letters.
[3] Jian-Dong Huang,et al. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model , 2012, Neurobiology of Aging.
[4] A. Buisson,et al. Activation of Extrasynaptic, But Not Synaptic, NMDA Receptors Modifies Amyloid Precursor Protein Expression Pattern and Increases Amyloid-β Production , 2010, The Journal of Neuroscience.
[5] R. Gainetdinov,et al. Akt/GSK3 signaling in the action of psychotropic drugs. , 2009, Annual review of pharmacology and toxicology.
[6] Pravir Kumar,et al. The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid. , 2009, Molecular biology of the cell.
[7] R. Wang,et al. Changes in hippocampal synapses and learning-memory abilities in age-increasing rats and effects of tetrahydroxystilbene glucoside in aged rats , 2007, Neuroscience.
[8] B. Hyman,et al. Expression of APP pathway mRNAs and proteins in Alzheimer’s disease , 2007, Brain Research.
[9] E. F. da Cruz e Silva,et al. Altered Subcellular Distribution of the Alzheimer's Amyloid Precursor Protein Under Stress Conditions , 2007, Annals of the New York Academy of Sciences.
[10] Lan Zhang,et al. Learning-memory deficit with aging in APP transgenic mice of Alzheimer's disease and intervention by using tetrahydroxystilbene glucoside , 2006, Behavioural Brain Research.
[11] N. Cairns,et al. Amyloid precursor protein mRNA levels in Alzheimer's disease brain. , 2004, Brain research. Molecular brain research.
[12] J. Lucas,et al. Glycogen Synthase Kinase-3 Plays a Crucial Role in Tau Exon 10 Splicing and Intranuclear Distribution of SC35 , 2004, Journal of Biological Chemistry.
[13] Christina A. Wilson,et al. GSK-3α regulates production of Alzheimer's disease amyloid-β peptides , 2003, Nature.
[14] R. Jope,et al. The multifaceted roles of glycogen synthase kinase 3β in cellular signaling , 2001, Progress in Neurobiology.
[15] B. Graveley. Sorting out the complexity of SR protein functions. , 2000, RNA.
[16] B. Burgering,et al. Essential Role for Protein Kinase B (PKB) in Insulin-induced Glycogen Synthase Kinase 3 Inactivation , 1998, The Journal of Biological Chemistry.
[17] J. Ávila,et al. Lithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neurons , 1997, FEBS letters.
[18] K. Beyreuther,et al. APP Gene Family Alternative Splicing Generates Functionally Related Isoforms a , 1996, Annals of the New York Academy of Sciences.
[19] B. Allinquant,et al. In Vivo Neuronal Synthesis and Axonal Transport of Kunitz Protease Inhibitor (KPI)‐Containing Forms of the Amyloid Precursor Protein , 1994, Journal of neurochemistry.
[20] C. Masters,et al. Beta A4-amyloid protein precursor mRNA isoforms without exon 15 are ubiquitously expressed in rat tissues including brain, but not in neurons. , 1994, The Journal of biological chemistry.
[21] J. Hardy,et al. Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.
[22] D. Selkoe. In the beginning ... , 1991, Nature.
[23] Ru-yi Zhang,et al. Tetrahydroxystilbene glucoside ameliorates memory and movement functions, protects synapses and inhibits α-synuclein aggregation in hippocampus and striatum in aged mice. , 2015, Restorative neurology and neuroscience.
[24] Ru-yi Zhang,et al. Tetrahydroxystilbene glucoside antagonizes age-related α-synuclein overexpression in the hippocampus of APP transgenic mouse model of Alzheimer's disease. , 2013, Restorative neurology and neuroscience.
[25] Xiang-Dong Fu,et al. SR proteins and related factors in alternative splicing. , 2007, Advances in experimental medicine and biology.
[26] P. Cohen,et al. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. , 2001, Molecular Cell.
[27] J. Hardy,et al. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.